Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
Add more filters










Publication year range
1.
J Dent Res ; 94(3): 412-20, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25535204

ABSTRACT

Amelogenins are the most abundant protein species in forming dental enamel, taken to regulate crystal shape and crystal growth. Unprotonated amelogenins can bind protons, suggesting that amelogenins could regulate the pH in enamel in situ. We hypothesized that without amelogenins the enamel would acidify unless ameloblasts were buffered by alternative ways. To investigate this, we measured the mineral and chloride content in incisor enamel of amelogenin-knockout (AmelX(-/-)) mice and determined the pH of enamel by staining with methyl-red. Ameloblasts were immunostained for anion exchanger-2 (Ae2), a transmembrane pH regulator sensitive for acid that secretes bicarbonate in exchange for chloride. The enamel of AmelX(-/-) mice was 10-fold thinner, mineralized in the secretory stage 1.8-fold more than wild-type enamel and containing less chloride (suggesting more bicarbonate secretion). Enamel of AmelX(-/-) mice stained with methyl-red contained no acidic bands in the maturation stage as seen in wild-type enamel. Secretory ameloblasts of AmelX(-/-) mice, but not wild-type mice, were immunopositive for Ae2, and stained more intensely in the maturation stage compared with wild-type mice. Exposure of AmelX(-/-) mice to fluoride enhanced the mineral content in the secretory stage, lowered chloride, and intensified Ae2 immunostaining in the enamel organ in comparison with non-fluorotic mutant teeth. The results suggest that unprotonated amelogenins may regulate the pH of forming enamel in situ. Without amelogenins, Ae2 could compensate for the pH drop associated with crystal formation.


Subject(s)
Amelogenesis/physiology , Amelogenin/physiology , Ameloblasts/chemistry , Ameloblasts/ultrastructure , Amelogenesis/drug effects , Amelogenin/genetics , Animals , Azo Compounds , Buffers , Chloride-Bicarbonate Antiporters/analysis , Chlorides/analysis , Coloring Agents , Crystallization , Dental Enamel/chemistry , Dental Enamel/ultrastructure , Electron Probe Microanalysis/methods , Enamel Organ/drug effects , Enamel Organ/ultrastructure , Fluorides/pharmacology , Hydrogen-Ion Concentration , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Electron , Minerals/analysis , X-Ray Microtomography/methods
2.
J Dent Res ; 93(1): 96-102, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24170372

ABSTRACT

Enamel fluorosis is an irreversible structural enamel defect following exposure to supraoptimal levels of fluoride during amelogenesis. We hypothesized that fluorosis is associated with excess release of protons during formation of hypermineralized lines in the mineralizing enamel matrix. We tested this concept by analyzing fluorotic enamel defects in wild-type mice and mice deficient in anion exchanger-2a,b (Ae2a,b), a transmembrane protein in maturation ameloblasts that exchanges extracellular Cl(-) for bicarbonate. Defects were more pronounced in fluorotic Ae2a,b (-/-) mice than in fluorotic heterozygous or wild-type mice. Phenotypes included a hypermineralized surface, extensive subsurface hypomineralization, and multiple hypermineralized lines in deeper enamel. Mineral content decreased in all fluoride-exposed and Ae2a,b(-/-) mice and was strongly correlated with Cl(-). Exposure of enamel surfaces underlying maturation-stage ameloblasts to pH indicator dyes suggested the presence of diffusion barriers in fluorotic enamel. These results support the concept that fluoride stimulates hypermineralization at the mineralization front. This causes increased release of protons, which ameloblasts respond to by secreting more bicarbonates at the expense of Cl(-) levels in enamel. The fluoride-induced hypermineralized lines may form barriers that impede diffusion of proteins and mineral ions into the subsurface layers, thereby delaying biomineralization and causing retention of enamel matrix proteins.


Subject(s)
Chloride-Bicarbonate Antiporters/drug effects , Fluorides/adverse effects , Fluorosis, Dental/etiology , Ameloblasts/drug effects , Ameloblasts/pathology , Amelogenesis/drug effects , Amelogenesis/genetics , Animals , Bicarbonates/analysis , Chloride-Bicarbonate Antiporters/analysis , Chloride-Bicarbonate Antiporters/genetics , Chlorides/analysis , Coloring Agents , Dental Enamel/chemistry , Dental Enamel/drug effects , Dental Enamel/pathology , Dental Enamel Proteins/analysis , Diffusion , Female , Fluorosis, Dental/genetics , Fluorosis, Dental/pathology , Heterozygote , Homozygote , Hydrogen-Ion Concentration , Indicators and Reagents , Mice , Mice, Knockout , Minerals/analysis , Phenotype , Rats , Rats, Wistar , Tooth Calcification/drug effects , Tooth Calcification/genetics
3.
Caries Res ; 46(6): 575-80, 2012.
Article in English | MEDLINE | ID: mdl-22947666

ABSTRACT

Excessive intake of fluoride (F) by young children results in the formation of enamel subsurface porosities and pits, called enamel fluorosis. In this study, we used a single high dose of F administered to hamster pups to determine the stage of ameloblasts most affected by F and whether pit formation was related to F-related sub-ameloblastic cyst formation. Hamster pups received a single subcutaneous injection of either 20 mg or 40 mg NaF/kg body weight, were sacrificed 24 h later, and the number of cysts formed in the first molars were counted. Other pups were sacrificed 8 days after F injection, when the first molars had just erupted, to score for enamel defects. All F-injected pups formed enamel defects in the upper half of the cusps in a dose-dependent way. After injection of 20 mg NaF/kg, an average of 2.5 white spots per molar was found but no pits. At 40 mg NaF/kg, almost 4.5 spots per molar were counted as well as 2 pits per molar. The defects in erupted enamel were located in the upper half of the cusps, sites where cysts had formed at the transition stage of ameloblast differentiation. These results suggest that transitional ameloblasts, located between secretory- and maturation-stage ameloblasts, are most sensitive to the effects of a single high dose of F. F-induced cysts formed earlier at the pre-secretory stage were not correlated to either white spots or enamel pits, suggesting that damaged ameloblasts overlying a F-induced cyst regenerate and continue to form enamel.


Subject(s)
Ameloblasts/drug effects , Dental Enamel/drug effects , Enamel Organ/physiology , Fluorosis, Dental/pathology , Sodium Fluoride/adverse effects , Ameloblasts/pathology , Animals , Cricetinae , Cysts/chemically induced , Enamel Organ/drug effects , Microtomy , Plastic Embedding , Porosity , Regeneration , Sodium Fluoride/administration & dosage
4.
J Dent Res ; 90(6): 782-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21364089

ABSTRACT

Enamel biomineralization results in a release of protons into the enamel matrix, causing an acidification of the local microenvironment. This acidification, which may be enhanced by more rapid mineral deposition in the presence of fluoride, must be neutralized by the overlying ameloblasts. The electrogenic sodium bicarbonate co-transporter NBCe1 has been localized in mouse ameloblasts, and has been proposed to have a role in matrix pH regulation. In this study, transcript analysis by PCR showed NBCe1-A present in human ameloblasts, whereas mouse ameloblasts expressed NBCe1-B. In situ hybridization and qPCR in mouse and fetal human incisors showed that NBCe1 mRNA was up-regulated as ameloblasts differentiated. Ingestion of 50 ppm fluoride resulted in an up-regulation of NBCe1 mRNA in maturation-stage mouse ameloblasts in vivo, as compared with controls. NBCe1 expression was up-regulated by low pH, but not by fluoride, in human ameloblast-lineage cells in vitro. The up-regulation of NBCe1 in vivo as enamel maturation and mineralization progressed provides evidence that NBCe1 participates in pH modulation during enamel formation. Up-regulation of NBCe1 in fluorosed maturation ameloblasts in vivo, with no effect of fluoride in vitro, supports the hypothesis that fluoride-enhanced mineral deposition results in acidification of the mineralizing enamel matrix.


Subject(s)
Ameloblasts/metabolism , Amelogenesis/genetics , Fluorides/metabolism , Gene Expression Regulation, Developmental/drug effects , Sodium-Bicarbonate Symporters/genetics , Amelogenesis/drug effects , Animals , Cells, Cultured , Extracellular Matrix/metabolism , Female , Fluorides/pharmacology , Humans , Hydrogen-Ion Concentration , Mice , Mice, Inbred Strains , Sodium-Bicarbonate Symporters/metabolism , Tooth Calcification , Up-Regulation
5.
Arch Oral Biol ; 56(3): 238-43, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21277565

ABSTRACT

White opacities and pits are developmental defects in enamel caused by high intake of fluoride (F) during amelogenesis. We tested the hypothesis that these enamel pits develop at locations where F induces the formation of sub-ameloblastic cysts. We followed the fate of these cysts during molar development over time. Mandibles from hamster pups injected with 20mg NaF/kg at postnatal day 4 were excised from 1h after injection till shortly after tooth eruption, 8 days later. Tissues were histologically processed and cysts located and measured. Cysts were formed at early secretory stage and transitional stage of amelogenesis and detected as early 1h after injection. The number of cysts increased from 1 to almost 4 per molar during the first 16h post-injection. The size of the cysts was about the same, i.e., 0.46±0.29×10(6)µm(3) at 2h and 0.50±0.35×10(7)µm(3) at 16h post-injection. By detachment of the ameloblasts the forming enamel surface below the cyst was cell-free for the first 16h post-injection. With time new ameloblasts repopulated and covered the enamel surface in the cystic area. Three days after injection all cysts had disappeared and the integrity of the ameloblastic layer restored. After eruption, white opaque areas with intact enamel surface were found occlusally at similar anatomical locations as late secretory stage cysts were seen pre-eruptively. We conclude that at this moderate F dose, the opaque sub-surface defects with intact surface enamel (white spots) are the consequence of the fluoride-induced cystic lesions formed earlier under the late secretory-transitional stage ameloblasts.


Subject(s)
Amelogenesis/drug effects , Cariostatic Agents/adverse effects , Dental Enamel Hypoplasia/etiology , Mandibular Diseases/chemically induced , Odontogenic Cysts/chemically induced , Sodium Fluoride/adverse effects , Tooth Germ/drug effects , Ameloblasts/drug effects , Ameloblasts/pathology , Animals , Animals, Newborn , Cricetinae , Mandible , Mandibular Diseases/complications , Molar , Odontogenic Cysts/complications
6.
J Dent Res ; 88(10): 877-93, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19783795

ABSTRACT

Intake of excess amounts of fluoride during tooth development cause enamel fluorosis, a developmental disturbance that makes enamel more porous. In mild fluorosis, there are white opaque striations across the enamel surface, whereas in more severe cases, the porous regions increase in size, with enamel pitting, and secondary discoloration of the enamel surface. The effects of fluoride on enamel formation suggest that fluoride affects the enamel-forming cells, the ameloblasts. Studies investigating the effects of fluoride on ameloblasts and the mechanisms of fluorosis are based on in vitro cultures as well as animal models. The use of these model systems requires a biologically relevant fluoride dose, and must be carefully interpreted in relation to human tooth formation. Based on these studies, we propose that fluoride can directly affect the ameloblasts, particularly at high fluoride levels, while at lower fluoride levels, the ameloblasts may respond to local effects of fluoride on the mineralizing matrix. A new working model is presented, focused on the assumption that fluoride increases the rate of mineral formation, resulting in a greater release of protons into the forming enamel matrix.


Subject(s)
Ameloblasts/drug effects , Cariostatic Agents/pharmacology , Fluorides/pharmacology , Fluorosis, Dental/etiology , Amelogenesis/drug effects , Animals , Cariostatic Agents/adverse effects , Cariostatic Agents/analysis , Cells, Cultured , Dental Enamel/drug effects , Disease Models, Animal , Fluorides/adverse effects , Fluorides/blood , Fluorosis, Dental/pathology , Humans , Models, Biological , Odontogenesis/drug effects , Tooth Calcification/drug effects
7.
Matrix Biol ; 27(2): 119-27, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18042363

ABSTRACT

One of the mechanisms by which epithelial cells regulate intracellular pH is exchanging bicarbonate for Cl(-). We tested the hypothesis that in ameloblasts the anion exchanger-2 (Ae2) is involved in pH regulation during maturation stage amelogenesis. Quantitative X-ray microprobe mineral content analysis, scanning electron microscopy, histology, micro-computed tomography and Ae2 immuno-localisation analyses were applied to Ae2-deficient and wild-type mouse mandibles. Immuno-localisation of Ae2 in wild-type mouse incisors showed a very strong expression of Ae2 in the basolateral membranes of the maturation stage ameloblasts. Strikingly, zones of contiguous ameloblasts were found within the maturation stage in which Ae2 expression was extremely low as opposed to neighbouring cells. Maturation stage ameloblasts of the Ae2(a,b)(-/-) mice failed to stain for Ae2 and showed progressive disorganisation as enamel development advanced. Maturation stage enamel of the Ae2(a,b)(-/-) mice contained substantially less mineral and more protein than wild-type enamel as determined by quantitative X-ray microanalysis. Incisor enamel was more severely affected than molar enamel. Scanning electron microscopy revealed that the rod-inter-rod structures of the Ae2(a,b)(-/-) mice incisor enamel were absent. Mineral content of dentine and bone of Ae2(a,b)(-/-) mice was not significantly different from wild-type mice. The enamel from knockout mouse teeth wore down much faster than that from wild-type litter mates. Basolateral bicarbonate secretion via the anionic exchanger Ae2 is essential for mineral growth in the maturation stage enamel. The observed zonal expression of Ae2 in the maturation stage ameloblasts is in line with a model for cyclic proton secretion during maturation stage amelogenesis.


Subject(s)
Amelogenesis/physiology , Anion Transport Proteins/physiology , Antiporters/physiology , Dental Enamel/growth & development , Tooth/growth & development , Ameloblasts/metabolism , Amelogenesis/genetics , Animals , Anion Transport Proteins/genetics , Antiporters/genetics , Bone and Bones/chemistry , Dental Enamel/metabolism , Dental Enamel/ultrastructure , Dentin/chemistry , Incisor/metabolism , Mice , Mice, Inbred Strains , Mice, Knockout , Microscopy, Electron, Scanning , Minerals/analysis , Models, Biological , Molar/metabolism , Protein Isoforms/genetics , Protein Isoforms/physiology , SLC4A Proteins , Tooth/metabolism , Tooth Calcification/genetics , Tooth Calcification/physiology
8.
Eur J Oral Sci ; 114 Suppl 1: 111-5; discussion 127-9, 380, 2006 May.
Article in English | MEDLINE | ID: mdl-16674671

ABSTRACT

We tested the hypothesis that the sensitivity of forming dental enamel to fluoride (F-) is ameloblast developmental stage-dependent and that enamel mineralization disturbances at the surface of fluorotic enamel are caused by damage to late-secretory- and transitional-stage ameloblasts. Four-day-old hamsters received a single intraperitoneal dose of 2.5-20 mg NaF/kg body weight and were examined, 24 h later, by histology and histochemistry. A single dose of >or=5 mg of NaF/kg induced the formation of a hyper- followed by a hypomineralized band in the secretory enamel, without changing the ameloblast structure. At 10 mg of NaF/kg, cystic lesions became apparent under isolated populations of distorted late-secretory- and transitional-stage ameloblasts. Staining with von Kossa stain showed that the enamel under these lesions was hypermineralized. At 20 mg of NaF/kg, cystic lesions containing necrotic cells were also found in the early stages of secretory amelogenesis and were also accompanied with hypermineralization of the enamel surface. We concluded that the sensitivity to F- is ameloblast developmental stage-dependent. Groups of transitional ameloblasts are most sensitive, followed by those at early secretory stages. These data suggest that a F-induced increase in cell death in the transitional-stage ameloblasts accompanies the formation of cystic lesions, which may explain the formation of enamel pits seen clinically in erupted teeth.


Subject(s)
Ameloblasts/drug effects , Amelogenesis/drug effects , Cariostatic Agents/pharmacology , Dental Enamel/drug effects , Fluorides/pharmacology , Ameloblasts/cytology , Animals , Cariostatic Agents/administration & dosage , Cell Cycle , Cell Death , Coloring Agents , Cricetinae , Dose-Response Relationship, Drug , Fluorides/administration & dosage , Fluorosis, Dental/etiology , Fluorosis, Dental/pathology , Injections, Intraperitoneal , Necrosis , Random Allocation , Sodium Fluoride/administration & dosage , Sodium Fluoride/pharmacology , Time Factors , Tooth Calcification/drug effects , Tooth Germ/cytology , Tooth Germ/drug effects
9.
Antimicrob Agents Chemother ; 49(6): 2438-44, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15917544

ABSTRACT

The therapeutic efficacy of an antimicrobial peptide, human lactoferrin 1-11 (hLF1-11), was investigated in a model of chronic methicillin-resistant Staphylococcus aureus (MRSA) (gentamicin susceptible) osteomyelitis in rabbits. We incorporated 50 mg hLF1-11/g or 50 mg gentamicin/g cement powder into a calcium phosphate bone cement (Ca-P) and injected it into the debrided tibial cavity, creating a local drug delivery system. The efficacy of hLF1-11 and gentamicin was compared to that of a sham-treated control (plain bone cement) (n=6) and no treatment (infected only) (n=5). The results were evaluated by microbiology, radiology, and histology. MRSA was recovered from all tibias in both control groups (n=11). On the other hand, hLF1-11 and gentamicin significantly reduced the bacterial load. Furthermore, no growth of bacteria was detected in five out of eight and six out of eight specimens of the hLF1-11- and gentamicin-treated groups, respectively. These results were confirmed by a significant reduction of the histological disease severity score by hLF1-11 and gentamicin compared to both control groups. The hLF1-11-treated group also had a significantly lower radiological score compared to the gentamicin-treated group. This study demonstrates the efficacy of hLF1-11 incorporated into Ca-P bone cement as a possible therapeutic strategy for the treatment of osteomyelitis, showing efficacy comparable to that of gentamicin. Therefore, the results of this study warrant further preclinical investigations into the possibilities of using hLF1-11 for the treatment of osteomyelitis.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Gentamicins/therapeutic use , Methicillin Resistance , Osteomyelitis/drug therapy , Peptide Fragments/therapeutic use , Staphylococcus aureus/drug effects , Animals , Anti-Bacterial Agents/administration & dosage , Bone Cements , Calcium Phosphates , Chronic Disease , Disease Models, Animal , Drug Carriers , Female , Gentamicins/administration & dosage , Humans , Lactoferrin , Osteomyelitis/microbiology , Peptide Fragments/administration & dosage , Rabbits , Radiography , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Tibia/diagnostic imaging , Tibia/microbiology , Treatment Outcome
10.
Biomaterials ; 26(28): 5717-26, 2005 Oct.
Article in English | MEDLINE | ID: mdl-15878377

ABSTRACT

The objective of this study was to investigate the release mechanism and kinetics of the antimicrobial peptide, Dhvar-5, both alone and in combination with gentamicin, from a standard commercial polymethyl methacrylate (PMMA) bone cement. Different amounts of Dhvar-5 were mixed with the bone cement powders of Osteopal and the gentamicin-containing Osteopal G bone cement and their release kinetics from the polymerized cement were investigated. Additionally, the internal structure of the bone cements were analysed by scanning electron microscopy (SEM) of the fracture surfaces. Secondly, porosity was investigated with the mercury intrusion method and related to the observed release profiles. In order to obtain an insight into the mechanical characteristics of the bone cement mixtures, the compressive strength of Osteopal and Osteopal G with Dhvar-5 was also investigated. The total Dhvar-5 release reached 96% in the 100 mg Dhvar-5/g Osteopal cement, whereas total gentamicin release from Osteopal G reached only 18%. Total gentamicin release increased significantly to 67% with the addition of 50mg Dhvar-5/g, but the Dhvar-5 release was not influenced. SEM showed an increase of dissolved gentamicin crystals with the addition of Dhvar-5. The mercury intrusion results suggested an increase of small pores (< 0.1 microm) with the addition of Dhvar-5. Compressive strength of Osteopal was reduced by the addition of Dhvar-5 and gentamicin, but still remained above the limit prescribed by the ISO standard for clinical bone cements. We therefore conclude that the antimicrobial peptide, Dhvar-5, was released in high amounts from PMMA bone cement. When used together with gentamicin sulphate, Dhvar-5 made the gentamicin crystals accessible for the release medium presumably through increased micro-porosity (< 0.1 microm) resulting in a fourfold increase of gentamicin release.


Subject(s)
Bone Cements/chemistry , Delayed-Action Preparations/chemistry , Gentamicins/chemistry , Polymethyl Methacrylate/chemistry , Salivary Proteins and Peptides/chemistry , Antimicrobial Cationic Peptides/administration & dosage , Antimicrobial Cationic Peptides/analysis , Antimicrobial Cationic Peptides/chemistry , Bone Cements/analysis , Coated Materials, Biocompatible , Compressive Strength , Delayed-Action Preparations/analysis , Diffusion , Gentamicins/administration & dosage , Histatins , Materials Testing , Polymethyl Methacrylate/administration & dosage , Salivary Proteins and Peptides/administration & dosage , Salivary Proteins and Peptides/analysis
11.
J Antimicrob Chemother ; 54(6): 1078-84, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15537700

ABSTRACT

OBJECTIVES: The continued rise in drug-resistant pathogens has led to global research efforts into new antimicrobial agents. A promising class of new agents are the antimicrobial peptides. The aim of the study was to investigate the efficacy of the antimicrobial peptide Dhvar-5 in a prophylactic, methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis model. METHODS: Dhvar-5 (12 mg or 24 mg/rabbit) was incorporated into polymethyl methacrylate (PMMA) beads as a local drug delivery system. For comparison, plain beads (control) and beads containing gentamicin as a sulphate (10 mg or 24 mg per rabbit) were also prepared. The beads were inserted into the inoculated femoral cavity of 36 rabbits, and 1 week later they were killed. The presence and severity of MRSA osteomyelitis was assessed by culture and histology. RESULTS: Both the 24 mg Dhvar-5 beads and the 24 mg gentamicin sulphate beads significantly reduced the bacterial load of the inoculated femora compared with the control chain. Although a 24 mg Dhvar-5 dose inhibited MRSA growth, it did not completely sterilize the femora. Sterilization occurred only in some of the gentamicin-treated specimens. CONCLUSION: We conclude that both the gentamicin beads and the Dhvar-5 beads were only partially effective at preventing MRSA infection in this model.


Subject(s)
Anti-Bacterial Agents/pharmacology , Gentamicins/pharmacology , Methicillin Resistance , Osteomyelitis/prevention & control , Peptides/pharmacology , Staphylococcal Infections/prevention & control , Staphylococcus aureus/drug effects , Animals , Antibiotic Prophylaxis , Disease Models, Animal , Femur/microbiology , Histatins , Humans , Microspheres , Osteomyelitis/microbiology , Peptides/chemistry , Polymethacrylic Acids/administration & dosage , Rabbits , Salivary Proteins and Peptides/pharmacology , Staphylococcal Infections/microbiology
12.
J Antimicrob Chemother ; 52(5): 853-5, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14519679

ABSTRACT

OBJECTIVES: In order to identify possible drug delivery systems against resistant bone infection, we determined the release of the antimicrobial peptide (AMP) human lactoferrin 1-11 (hLF1-11) from commercially available bone substitutes. METHODS: We combined six calcium phosphate cements and six granule-types with 5 mg/g hLF1-11 and measured its availability and release in vitro from cements (7 days) and granules (3 days). The integrity and antimicrobial activity of the hLF1-11 that was released during the first 24 h were measured, using mass spectrometry, and a killing assay on methicillin-resistant Staphylococcus aureus (MRSA). RESULTS: Most of the cements showed burst release followed by low-level continuous release, whereas the coated granules showed high burst release for 24 h. After release the peptide was active (in nine of 12 materials) and intact. CONCLUSIONS: Different release profiles may be obtained by choosing the appropriate carrier, which supports the feasibility of biodegradable carriers releasing AMPs against resistant infections.


Subject(s)
Bone Substitutes/chemistry , Calcium Phosphates/chemistry , Drug Delivery Systems/methods , Peptide Fragments/chemistry , Peptide Fragments/pharmacology , Staphylococcus aureus/drug effects , Biodegradation, Environmental , Humans , Lactoferrin , Mass Spectrometry , Methicillin Resistance
13.
J Antimicrob Chemother ; 51(6): 1359-64, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12716782

ABSTRACT

Osteomyelitis is still a major cause of morbidity and remains a difficult complication to treat in orthopaedic surgery. The treatment of choice is a combination of systemic and local antibiotics. The insertion of gentamicin-loaded polymethylmethacrylate (PMMA) beads into the bone results in high local concentrations of gentamicin and low systemic concentrations. However, the effectiveness of this treatment is being hampered by the emergence of antimicrobial resistance. New antimicrobial agents are therefore needed. One new class of promising antibiotics is antimicrobial peptides (AMP). Derived from natural human peptides, these have a low tendency to induce antimicrobial resistance. Dhvar-5 is an antimicrobial peptide based on histatin-5, which is found in human saliva and consists of 14 amino acids. It has demonstrated bactericidal activity in vitro. In order to develop a new local treatment using Dhvar-5 for osteomyelitis, we investigated its release from PMMA beads and its antimicrobial activity against a clinical isolate of methicillin-resistant Staphylococcus aureus (MRSA) before and after release from PMMA beads. Specific amounts of Dhvar-5 were incorporated into PMMA mini beads, containing 120, 600 and 1200 microg of Dhvar-5, respectively. Dhvar-5 was released from the beads in all three groups. Total release from the 120 microg beads was 9 microg per bead after 7 days. However, the release per bead in the 600 and 1200 microg beads was far more, respectively, 416 and 1091 microg over a 28 day period. After release, the Dhvar-5 also retained its antimicrobial activity against MRSA. On the basis of these data we conclude that the amount of Dhvar-5 release from PMMA beads is not proportionate to the amount incorporated; instead, it demonstrated an exponential relationship to the amount of total peptide released. Furthermore, the released peptide remained biologically active against a clinical isolate of MRSA.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Microspheres , Peptides/pharmacokinetics , Polymethacrylic Acids/pharmacokinetics , Salivary Proteins and Peptides/pharmacokinetics , Anti-Bacterial Agents/administration & dosage , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/pharmacokinetics , Dose-Response Relationship, Drug , Histatins , Humans , Osteomyelitis/drug therapy , Peptides/administration & dosage , Polymethacrylic Acids/administration & dosage , Salivary Proteins and Peptides/administration & dosage
14.
J Clin Periodontol ; 30(3): 261-70, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12631185

ABSTRACT

OBJECTIVES: To study in detail the performance of deproteinized cancellous bovine bone (DPBB, Bio-Osso) granules as a bone substitute, a histomorphometric was performed on five patients treated with DPBB for reconstruction of the severely atrophic maxilla. MATERIAL AND METHODS: DPBB was used as mixture with autogenous bone particles, in concentrations that increased from 20% to 100% DPBB, with the time of healing increasing accordingly from 5 to 8 months. A total of 20 vertical biopsies was taken at the time of fixture installation and used for histomorphometry as undecalcified Goldner stained sections. RESULTS: The results show that in all cases, the DPBB granules had been interconnected by bridges of vital newly formed bone. The volume of bone in the grafted area correlated inversely with the concentration of DPBB grafted, and varied between 37% and 23%. However, the total volume of mineralized material (bone plus DPI3B granules) remained within the same range in all five patients (between 53% and 59%). The high values for osteoid and resorption surface, and the presence of tartrate-resistant acid phosphatase-positive multinucleated osteoclasts in resorption lacunae, indicated that bone remodeling was very active in all grafts. Osteoclasts were also observed in shallow resorption pits on DPBB surfaces. The percentage DPBB surface in contact with bone remained stable at about 35% and could not be related to the proportion of DPBB grafted. CONCLUSION: Although the number of patients examined was limited, the data suggest that deproteinized cancellous bovine bone, preferably combined with autogenous bone particles, is a suitable material for sinus floor elevation in the severely atrophic human maxilla.


Subject(s)
Alveolar Ridge Augmentation/methods , Bone Matrix/transplantation , Bone Substitutes/therapeutic use , Maxilla/surgery , Maxillary Sinus/surgery , Minerals/therapeutic use , Aged , Animals , Atrophy , Bone Matrix/pathology , Bone Resorption/pathology , Bone Transplantation/pathology , Calcification, Physiologic/physiology , Cattle , Dental Implantation, Endosseous , Female , Follow-Up Studies , Humans , Male , Maxilla/pathology , Maxillary Sinus/pathology , Middle Aged , Osteoclasts/pathology , Osteogenesis/physiology , Retrospective Studies , Time Factors , Wound Healing/physiology
15.
Connect Tissue Res ; 43(2-3): 456-65, 2002.
Article in English | MEDLINE | ID: mdl-12489198

ABSTRACT

Amelogenins are the major protein species synthesized by secretory ameloblasts and are believed to be involved in enamel mineralization. During enamel formation, amelogenins are progressively degraded into smaller fragments by protease activity. These amelogenin fragments are removed from the enamel extracellular space, thereby enabling full mineralization of the dental enamel. Enamel from fluorotic teeth is porous and contains more proteins and less mineral than sound enamel. In this study we examined the hypothesis that fluoride (F-) is capable of inhibiting the proteolysis of amelogenins in enamel being formed in organ culture. Hamster molar tooth germs in stages of secretory amelogenesis were pulse labeled in vitro with [3H]- or [14C] proline and subsequently pulse chased. The explants were exposed to F- at different days of chase (i.e., during secretory amelogenesis early after labeling, later after labeling or at stages just beyond secretory amelogenesis). Exposure of secretory stage explants to F- enhanced the release of radiolabeled fragments when F- was applied early after labeling but progressively less if applied later. In contrast, F- had no such effect in stages beyond secretion. The enhanced release of radiolabeled fragments in secretory stages was associated with a reduction of radioactivity in the soft tissue enamel organ indicating that fragmentation of enamel matrix proteins (mainly amelogenins) occurred intracellularly. Analysis by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) demonstrated that the fluorotic enamel contained less radiolabeled parent amelogenins (M(r) 28 kD and 26 kD) but more low-molecular-mass fragments than enamel from control explants. Our data indicate that F- promotes intracellular degradation of the newly synthesized parent amelogenins during secretory stage. Our in vitro data do not support the concept that F- impairs extracellular proteolysis of amelogenins, either in the secretory phase or in the stage just beyond the secretory phase.


Subject(s)
Amelogenesis/physiology , Dental Enamel Proteins/metabolism , Fluorides/pharmacology , Intracellular Fluid/metabolism , Amelogenin , Animals , Cricetinae , Drug Administration Schedule , Fluorides/administration & dosage , Organ Culture Techniques
16.
Clin Oral Implants Res ; 13(4): 428-36, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12175381

ABSTRACT

In this study, high concentrations of bioactive glass (BG) particles were compared with autogenous bone in their capacity to augment maxillary bone when grafted in the human sinus floor using a split mouth design. Three female patients with severe maxillary atrophy underwent bilateral sinus floor elevation and bone grafting using 80-100% BG particles (300-355 microm in size) mixed with 20% to 0% iliac crest bone particles at one (experimental) side, and 100% iliac crest derived bone particles at the other (control) side. A total of 22 bone biopsies was taken at the time of fixture installation; that is, at 4, 6 and 15 months after grafting, and processed for histology and histomorphometry. At the control (autogenous bone) sides, trabecular bone amounted to 39% of the biopsy volume in the graft (site) at 4 months, almost 41% at 6 months, and 42% at 15 months. This bone contained viable osteocytes and was mostly of mature, lamellar type. At the experimental (BG particles) sides, the graft consisted of 27% of mostly woven (and some lamellar) bone at 4 months, 36% (woven and lamellar) bone at 6 months, and 39% (mainly lamellar) bone at 15 months. The grafted BG particles started to excavate at 4 months and their centers gradually filled with bone tissue. As a consequence, the volume of BG particles in the biopsy decreased from 29% at 4 months to 15% at 6 months and 8% at 15 months. The BG particles appeared to resorb within 1-2 years by dissolution rather than by osteoclastic activity. Parameters for bone turnover (% osteoid surface, % resorption surface) indicated that bone remodeling was very active at both experimental and control sides, during more than 6 months. These results suggest that mixtures of mainly (80-90%) BG particles and some (10-20%) autogenous bone are effective for bone regeneration in the augmented sinus offer 6 months healing time, while about 12 months healing time is needed for 100% BG particles.


Subject(s)
Alveolar Ridge Augmentation/methods , Biocompatible Materials/therapeutic use , Bone Substitutes/therapeutic use , Bone Transplantation/methods , Glass , Maxilla/surgery , Maxillary Sinus/surgery , Absorbable Implants , Aged , Atrophy , Biocompatible Materials/chemistry , Biopsy , Bone Matrix/pathology , Bone Regeneration/physiology , Bone Remodeling/physiology , Bone Substitutes/chemistry , Bone Transplantation/pathology , Dental Implants , Female , Follow-Up Studies , Glass/chemistry , Humans , Maxilla/pathology , Maxillary Sinus/pathology , Middle Aged , Osteocytes/pathology , Solubility , Transplantation, Autologous , Wound Healing/physiology
17.
Histochem Cell Biol ; 113(4): 293-301, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10857481

ABSTRACT

An early event in apoptosis is exposure of phosphatidylserine, an aminophospholipid normally present in the inner leaflet of the plasma membranes, at the outer leaflet of the plasma membrane facing the extracellular space. Annexin V (Anx-V) is a 35-kDa protein with high affinity for phosphatidylserine, which can be applied to detect apoptosis. We injected biotin-labelled Anx-V intravenously in adult mice and examined the tissue distribution of Anx-V-labelled cells in dental and periodontal tissues using ABC-peroxidase histochemistry. In the continuously erupting incisors, strong and frequent immunostaining was observed in transitional stage and late maturation stage ameloblasts with less frequent staining in preameloblasts. Frequency of staining in odontoblasts and pulp cells was low but increased slightly at older stages of dentinogenesis. Labelling was also seen in phagocytic or phagocytic-like cells in the enamel organ and pulp. A positive staining was furthermore found in fibroblasts of the periodontal ligament in continuously erupting incisors and in fully erupted molar teeth. Staining intensity and the number of positive cells were enhanced by antigen retrieval using high-pressure cooking. We conclude that Anx-V-biotin labels dental cells in early stages of cell death and indirectly cells that have ingested labelled apoptotic cells during the course of the experiment. The data confirm that during amelogenesis most cell death occurs in transitional stage and late maturation stage ameloblasts. Thus, labelling with Anx-V is a useful marker for studying cell death and the dynamics of clearance of apoptotic cells during tooth development.


Subject(s)
Annexin A5 , Apoptosis , Biotin , Periodontium/pathology , Tooth/pathology , Animals , Biomarkers , Mice , Staining and Labeling
18.
J Oral Pathol Med ; 28(7): 293-6, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10432194

ABSTRACT

The aim of these studies was to find out whether intact neonatal pulp tissue containing residual epithelial cells can induce the development of a tooth-like structure in situ. First maxillary neonatal hamster molar pulps containing adhering undifferentiated epithelial cells were transplanted submucosally in the oral cavity of recipient mothers for periods ranging from 2-8 weeks and the tissues were then processed for light microscopy. Developing tooth-like structures containing mineralised tubular dentine, predentine and a vascularised pulp-like chamber lined with functional odontoblast-like cells were observed in the specimens within 2 weeks of transplantation. Enamel and root formation were not observed. These data indicate that neonatal dental pulp tissues containing epithelial cell remnants have the capacity to develop into tooth-like structures and that this could be the explanation for the development of tooth-like structures sometimes observed in infants after extraction of a natal tooth.


Subject(s)
Dental Pulp/growth & development , Dental Pulp/transplantation , Tooth/growth & development , Amelogenesis , Animals , Animals, Newborn , Calcification, Physiologic , Cricetinae , Dental Pulp/anatomy & histology , Epithelium/growth & development , Epithelium/transplantation , Female , Odontoblasts/cytology , Time Factors , Tissue Transplantation , Tooth/anatomy & histology , Tooth Germ/anatomy & histology , Tooth Germ/growth & development
19.
Cancer Detect Prev ; 23(4): 343-50, 1999.
Article in English | MEDLINE | ID: mdl-10403906

ABSTRACT

The aim of this study was to evaluate, under organ culture conditions, the cytotoxic effects of daunorubicin on tooth development. Three-day-old maxillary hamster second molars were exposed for 24 h in vitro to 108-10-4 M daunorubicin and then evaluated biochemically and histologically. At 10-6 M daunorubicin dose-dependently decreased tooth germ dry weight, cell proliferation ([3H]thymidine uptake), and insoluble [32P] phosphate uptake (phosphorylation of macromolecules). [45Ca]calcium uptake, a marker for mineralization, was significantly affected only at the highest concentration (10-4 M) tested. Histologically, 10-6 M daunorubicin induced necrosis of the proliferating but not the differentiated protein-secreting cells. At 10-4 M, however, all cells were dead. These results indicate that daunorubicin is particularly toxic to the proliferating cells of the tooth germ. Thus, it can be postulated that children treated with daunorubicin may develop defects in the erupted teeth mainly associated with those regions that were in the proliferating stage at the onset of anticancer chemotherapy.


Subject(s)
Antibiotics, Antineoplastic/adverse effects , Daunorubicin/adverse effects , Molar/drug effects , Tooth Germ/drug effects , Amelogenesis/drug effects , Animals , Animals, Newborn , Cell Differentiation/drug effects , Cell Division/drug effects , Child , Cricetinae , Dentinogenesis/drug effects , Dose-Response Relationship, Drug , Humans , Maxilla , Molar/cytology , Molar/growth & development , Organ Culture Techniques , Tooth Germ/cytology , Tooth Germ/growth & development
20.
Eur J Oral Sci ; 106 Suppl 1: 156-9, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9541219

ABSTRACT

Amongst the most frequently used drugs for the treatment of acute lymphoblastic leukaemia (ALL) belongs methotrexate (MTX), an inhibitor of pyrimidine (thymidine) synthesis. We examined effects of MTX on cell proliferation during tooth morphogenesis in organ culture by exposing hamster molar tooth germs to 10(-7) to 10(-3) M MTX for 24 h. In the presence of serum, only the highest concentration of MTX (10(-3) M) induced a small, nonsignificant decrease in cell mass without histological changes but, unexpectedly, increased uptake of [3H]thymidine. In serumless conditions increase in cell mass (dry weight) and incorporation of [3H]thymidine was lower than in serum-supplemented conditions. Exposure to MTX in serumless conditions reduced the increase in cell mass even further without histological changes and, again, strongly enhanced incorporation of [3H]thymidine to the same proportion as measured in the serum-supplemented cultures exposed to MTX. The data suggest that only exposure to high levels of MTX reduces proliferation activity, shown by reduction in cell mass. The enhanced [3H]thymidine uptake under MTX exposure was explained by blockage of the internal biosynthesis of thymidine, by which action more radiolabel was taken up from the medium. The data also suggest that serum contains (growth) factors that stimulate cell proliferation, thereby increasing cell mass and [3H]thymidine incorporation.


Subject(s)
Antimetabolites, Antineoplastic/toxicity , Methotrexate/toxicity , Tooth Germ/drug effects , Tooth Germ/growth & development , Animals , Antimetabolites, Antineoplastic/administration & dosage , Cell Division/drug effects , Child , Cricetinae , Culture Media, Serum-Free , Humans , In Vitro Techniques , Methotrexate/administration & dosage , Molar/cytology , Molar/drug effects , Molar/growth & development , Thymidine/metabolism , Tooth Germ/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...